Skip to main content
Equibles

Beneficial ownership — 13D / 13G

85,680 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.

Reporting person Issuer Schedule % of class Filed
Rubric Capital Management LP MREO Mereo BioPharma Group plc 13D/A 13.88% 3y
Danaos Investment Limited as Trustee of the 883 Trust DAC Danaos Corp 13D/A 47.3% 3y
Brookfield Oaktree Holdings, LLC IMPL Impel Pharmaceuticals Inc. Common Stock 13D/A 9.1% 3y
AH Bio Fund II, L.P. EQRX EQRx, Inc. Common Stock 13D/A 0% 3y
BROADWOOD PARTNERS, L.P. STAA Staar Surgical Co 13D/A 20.7% 3y
Campbell Richard D VTLE Vital Energy, Inc. 13G 6.34% 3y
H PARTNERS MANAGEMENT, LLC SIX Six Flags Entertainment Corp. 13D/A 13.65% 3y
J Arnold Wealth Management Co FAB First Trust Exchange-Traded AlphaDEX Fund 13G 11.7% 3y
RA CAPITAL MANAGEMENT, L.P. DSGN Design Therapeutics, Inc. 13G/A 0% 3y
PERCEPTIVE ADVISORS LLC CRGX CARGO Therapeutics, Inc. Common Stock 13G 8.4% 3y
Todd L. Boehly LXU Lsb Industries, Inc. 13D/A 20.6% 3y
Brian Corday DWTX Dogwood Therapeutics, Inc. 13G/A 6.84% 3y
F9 Investments, LLC (Single Member LLC with Thomas D. Sullivan Single Member) LL LL Flooring Holdings, Inc. 13D/A 8.8% 3y
GAMCO INVESTORS, INC. ET AL APRN Blue Apron Holdings, Inc. Class A Common Stock 13D/A 0% 3y
Family Trading Inc. TOPS Top Ships Inc. 13D/A 63.36% 3y
MV Management XI, L.L.C. ROVR Rover Group, Inc. Class A Common Stock 13D/A 3.2% 3y
GLOBAL VALUE INVESTMENT CORP. RMCF Rocky Mountain Chocolate Factory, Inc. 13D/A 14.86% 3y
Saba Capital Management, L.P. SABA Saba Capital Income & Opportunities Fund II 13D/A 19.54% 3y
NEUBERGER BERMAN GROUP LLC ETWO E2open Parent Holdings, Inc. 13D/A 13% 3y
Dayton Judd LFVN Lifevantage Corp 13D/A 6% 3y
Radoff Bradley Louis LFVN Lifevantage Corp 13D/A 6.8% 3y
Phoenix Financial Ltd. RDWR Radware Ltd 13G/A 4.87% 3y
Walgreens Boots Alliance, Inc. COR Cencora, Inc. 13D/A 15.29% 3y
Xiangmin Cui ALPN Alpine Immune Sciences, Inc. Common Stock 13D/A 14.1% 3y
Mitchell H. Gold ALPN Alpine Immune Sciences, Inc. Common Stock 13D/A 7.2% 3y
Steel Partners, Ltd. SPLP STEEL PARTNERS HOLDINGS L.P. 13D/A 48.7% 3y
Al Kapoor OPTX Syntec Optics Holdings, Inc. 13D 83.49% 3y
Indaba Capital Management, L.P. TRHC Tabula Rasa HealthCare, Inc. Common Stock 13D/A 0% 3y
Focus Impact BHAC Sponsor, LLC BHAC Focus Impact BH3 Acquisition Company Class A Common Stock 13D 71.6% 3y
GLOBAL VALUE INVESTMENT CORP. FLXS Flexsteel Industries Inc 13D 5.06% 3y
Dustin A. Moskovitz ASAN Asana, Inc. 13D/A 59.3% 3y
Aristotle Capital Management, LLC CINF Cincinnati Financial Corp 13G/A 0.01% 3y
Caledonia (Private) Investments Pty Ltd LAWIL Light & Wonder, Inc. 13G/A 9.36% 3y
J Arnold Wealth Management Co ACYN First Trust Exchange-Traded Fund 13G 28% 3y
Folius Digital Opportunities Master Fund Ltd. MATH Metalpha Technology Holding Ltd 13G 5.6% 3y
Saba Capital Management, L.P. BTX BlackRock Technology & Private Equity Term Trust 13D/A 14.95% 3y
FreshRealm, Inc. APRN Blue Apron Holdings, Inc. Class A Common Stock 13D/A 0% 3y
Saba Capital Management, L.P. NXJ NUVEEN NEW JERSEY QUALITY MUNICIPAL INCOME FUND 13D/A 10.9% 3y
Forager Fund, L.P. DLA Delta Apparel Inc. 13D/A 6.3% 3y
Harraden Circle Investments, LLC CNTM ConnectM Technology Solutions, Inc. 13G 5.13% 3y
Edenbrook Capital, LLC MCHX Marchex Inc 13D/A 37.67% 3y
Sylebra Capital Ltd AEVA Aeva Technologies, Inc. 13D/A 19.9% 3y
Pershing Square Capital Management, L.P. HHH Howard Hughes Holdings Inc. 13D/A 36.1% 3y
Jacobsen Per A. BLIN Bridgeline Digital, Inc. 13G/A 6.5% 3y
Barta Jan GRPN Groupon, Inc. 13D/A 24.6% 3y
Rubric Capital Management LP MREO Mereo BioPharma Group plc 13D/A 13.88% 3y
Shoshana Shendelman APLT Applied Therapeutics, Inc. Common Stock 13D/A 10.1% 3y
ORBIMED ADVISORS LLC ALPN Alpine Immune Sciences, Inc. Common Stock 13D/A 7.3% 3y
GARDNER LEWIS ASSET MANAGEMENT L P BSQR BSQUARE Corporation 13D 5.1% 3y
Saba Capital Management, L.P. NQP NUVEEN PENNSYLVANIA QUALITY MUNICIPAL INCOME FUND 13D/A 10.81% 3y